| Amy H Servais, MD | |
|
3916 N Intertech Ct, Appleton, WI 54913 | |
| (920) 996-1000 | |
| (920) 996-1050 |
| Full Name | Amy H Servais |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 3916 N Intertech Ct, Appleton, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326033291 | NPI | - | NPPES |
| 32406900 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 38120-020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
| Thedacare Regional Medical Center - Appleton Inc | Appleton, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Primary Care Associates Of Appleton, Ltd | 1052348612 | 31 |
News Archive
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that in a trial of its new Autopheresis-C® software, plasma-center professionals and donors reported faster plasma-collection times and an improved plasma-collection and donation experience. More than 90 percent of donors surveyed reported a decrease in their donation wait time. Donors who are more satisfied are more likely to donate regularly.
Starting this month Canadian and British scientists will begin collaborating on a study to examine human appetite- controlling hormones with a view to finding out what will increase PYY, a powerful hormone in the human body which dramatically diminishes appetite.
Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.
› Verified 7 days ago
| Entity Name | Primary Care Associates Of Appleton, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659305654 PECOS PAC ID: 1052348612 Enrollment ID: O20050726000158 |
News Archive
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that in a trial of its new Autopheresis-C® software, plasma-center professionals and donors reported faster plasma-collection times and an improved plasma-collection and donation experience. More than 90 percent of donors surveyed reported a decrease in their donation wait time. Donors who are more satisfied are more likely to donate regularly.
Starting this month Canadian and British scientists will begin collaborating on a study to examine human appetite- controlling hormones with a view to finding out what will increase PYY, a powerful hormone in the human body which dramatically diminishes appetite.
Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amy H Servais, MD 3916 N Intertech Ct, Appleton, WI 54913 Ph: (920) 996-1000 | Amy H Servais, MD 3916 N Intertech Ct, Appleton, WI 54913 Ph: (920) 996-1000 |
News Archive
OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that in a trial of its new Autopheresis-C® software, plasma-center professionals and donors reported faster plasma-collection times and an improved plasma-collection and donation experience. More than 90 percent of donors surveyed reported a decrease in their donation wait time. Donors who are more satisfied are more likely to donate regularly.
Starting this month Canadian and British scientists will begin collaborating on a study to examine human appetite- controlling hormones with a view to finding out what will increase PYY, a powerful hormone in the human body which dramatically diminishes appetite.
Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.
› Verified 7 days ago
Michael John Van Abel, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3916 N Intertech Ct, Appleton, WI 54913 Phone: 920-996-1000 | |
Stephen C Fuller, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3916 N Intertech Ct, Appleton, WI 54913 Phone: 920-996-1000 | |
Samuel James Heiks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3916 N Intertech Ct, Appleton, WI 54913 Phone: 920-996-1000 Fax: 920-996-1054 | |
Brittany E Goodrich-braun, Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 3925 N Gateway Dr, Appleton, WI 54913 Phone: 920-830-6877 | |
Dirk Jon Derksen, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Wagon Wheel Dr, Appleton, WI 54913 Phone: 920-731-6374 | |
Ms. Cynthia Frances Susedik, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3925 N Gateway Dr, Appleton, WI 54913 Phone: 920-830-6877 Fax: 920-993-5037 | |
N Carter Noble, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3329 N Richmond St, Appleton, WI 54911 Phone: 920-380-2715 |